The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist

Abstract

Lipopolysaccharide (LPS) antagonists inhibit the response of inflammatory cells to LPS, presumably by competitive inhibition, and may be of therapeutic value in the treatment of endotoxemia and sepsis. The inhibitory effects of some LPS antagonists are restricted to certain host species, however, as the same molecules can have significant endotoxic activity in other species. This species-specific recognition appears to be mediated by Toll-like receptor 4 (TLR4) and/or MD-2. We have shown previously that LPS from Rhodobacter sphaeroides ( RsLPS) is an LPS antagonist in human cells but an agonist (or LPS mimetic) in equine cells. In the present study, HEK293 cells were transfected with combinations of human and equine CD14, TLR4 and MD-2, and incubated with either RsLPS or with LPS from Escherichia coli as an endotoxin control. NF-κB activation was measured in a dual luciferase assay as an indicator of cellular activation. Our results indicate that E. colic LPS activated NF-κB in cells transfected with all combinations of the three receptor proteins, whereas RsLPS activated NF-κB only in cells expressing the single combination of equine TLR4 and equine MD-2. We conclude that the TLR4/MD-2 complex is responsible for recognition of RsLPS as an agonist in equine cells.

Keywords

Endotoxin antagonist equine NF-κB activation lipopolysaccharide receptor transfection

References

Barton MH , Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J Vet Intern Med 1999; 13: 457—464.

Steverink Pjgms , Sturk A. , Rutten Vpmg et al. Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: relation to clinical outcome. J Endotoxin Res 1995; 2: 289—299.

Barton MH , Morris DD , Norton N. , Prasse KW Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia . J Vet Intern Med 1998; 12: 26—35.

Golenbock DT , Hampton RY , Qureshi N. , Takayama K. , Raetz CR Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490—19498.

Zuckerman SH , Qureshi N. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun 1992; 60: 2581—2587.

Qureshi N. , Hofmann J. , Takayama K. , Vogel SN , Morrison DC Diphosphoryl lipid A from Rhodobacter sphaeroides: a novel lipopolysaccharide antagonist. In: Morrison DC , Ryan JL. (eds) Novel therapeutic strategies in the treatment of sepsis. New York: Marcel Dekker, 1996;; 111—131.

Kovach NL , Yee E. , Munford RS , Raetz CR , Harlan JM Lipid IVa inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J Exp Med 1990; 172: 77—84.

Delude RL , Savedra Jr R. , Zhao H. et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995; 92: 9288—9292.

Aida Y. , Kusumoto K. , Nakatomi K. , Takada H. , Pabst MJ , Maeda K. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J Leukoc Biol 1995; 58: 675—682.

10.

Qureshi N. , Takayama K. , Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991; 59: 441—444.

11.

Strittmatter W. , Weckesser J. , Salimath PV , Galanos C. Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol 1983; 155: 153—158.

12.

Lien E. , Means TK , Heine H. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497—504.

13.

Poltorak A. , Ricciardi-Castagnoli P. , Citterio S. , Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation . Proc Natl Acad Sci USA 2000; 97: 2163—2167.

14.

Akashi S. , Nagai Y. , Ogata H. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13: 1595—1599.

15.

Hajjar AM , Ernst RK , Tsai JH , Wilson CB , Miller SI Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002; 3: 354—359.

16.

Muroi M. , Ohnishi T. , Tanamoto K. MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect Immun 2002; 70: 3546—3550.

17.

Lohmann KL , Vandenplas M. , Barton MH , Moore JN Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells . J Endotoxin Res 2003; 9: 33—37.

18.

Mizushima S. , Nagata S. pEF-BOS, a powerful mammalian expression vector . Nucleic Acids Res 1990; 18: 5322.

19.

Chow JC , Young DW , Golenbock DT , Christ WJ , Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction . J Biol Chem 1999; 274: 10689—10692.

20.

Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002; 270: 109—120.

21.

Qureshi N. , Takayama K. , Hofmann J. , Zuckerman SH Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodobacter sphaeroides is an LPS antagonist and an inducer of corticosteroids. In: Levin J , Alving RS , Munford PL. (eds) Bacterial endotoxin: Recognition and effector mechanisms. Amsterdam: Elsevier, 1993; 361—371.

22.

Kitchens RL Role of CD14 in cellular recognition of bacterial lipopolysaccharides. In: Jack RS. (ed) CD14 in the inflammatory response. Basel: Karger, 2000; 61—82.

23.

Kirkland TN , Finley F. , Leturcq D. et al. Analysis of lipopolysaccharide binding by CD14. J Biol Chem 1993; 268: 24818—24823.

24.

Ulmer AJ , El-Samalouti VT , Rietschel ET , Flad HD , Dziarski R. CD14, and innate immune receptor for various bacterial cell wall components . In: Brade H , Opal SM , Vogel SN , Morrison DC. (eds) Endotoxin in Health and Disease. Basel: Marcel Dekker, 1999; 463—471.

25.

Frey EA , Miller DS , Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide . J Exp Med 1992; 176: 1665—1671.

26.

Shimazu R. , Akashi S. , Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777—1782.

27.

Takeuchi O. , Hoshino K. , Kawai T. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components . Immunity 1999; 11: 443—451.

28.

Visintin A. , Mazzoni A. , Spitzer JA , Segal DM Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 2001; 98: 12156—12161.

29.

Kawasaki K. , Akashi S. , Shimazu R. , Yoshida T, Miyake K, Nishijima M. Mouse Toll-like receptor 4·MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 2000; 275: 2251—2254.